Receptor Discordance in Metastatic Breast Cancer; a review of clinical and genetic subtype alterations from primary to metastatic disease
Breast Cancer Research and Treatment · 2024-10 · 207 (3) · 471-476
DOI: 10.1007/s10549-024-07431-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Breast Cancer Research and Treatment, online erschienen am 01.08.2024. Verfasst von Gavin P Dowling und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Lab, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland. gavindowling@rcsi.com. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Metastasis. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal College of Surgeons in Ireland.
Abstract (Originalsprache)
Purpose
Receptor and subtype discordance between primary breast tumours and metastases is a frequently reported phenomenon. The aim of this article is to review the current evidence on receptor discordance in metastatic breast cancer and to explore the benefit of performing a repeat biopsy in this context.
Methods
Searches were undertaken on PubMed and Clinicaltrials.gov for relevant publications and trials.
Conclusion
The current guidelines recommend offering to perform a biopsy of a metastatic lesion to evaluate receptor status. The choice of systemic therapy in metastatic disease is often based on the receptor status of the primary lesion. As therapeutic decision making is guided by subtype, biopsy of the metastatic lesion to determine receptor status may alter treatment. This article discusses discordance rates, the mechanisms of receptor discordance, the effect of discordance on treatment and survival outcomes, as well as highlighting some ongoing clinical trials in patients with metastatic breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Oncology Lab, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland. gavindowling@rcsi.com.
- The Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland. gavindowling@rcsi.com.
- The Department of Surgery, Beaumont Hospital, Dublin, Ireland. gavindowling@rcsi.com.
- The Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland.
- The Department of Surgery, Beaumont Hospital, Dublin, Ireland.
- Medical Oncology Lab, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
Förderung
- Royal College of Surgeons in Ireland
Zitieren
APA
Dowling, G. P., Keelan, S., Cosgrove, N. S., Daly, G. R., Giblin, K., Toomey, S., Hennessy, B. T., & Hill, A. D. K. (2024). Receptor Discordance in Metastatic Breast Cancer; a review of clinical and genetic subtype alterations from primary to metastatic disease. Breast Cancer Research and Treatment, 207(3), 471-476. https://doi.org/10.1007/s10549-024-07431-6
Vancouver
Dowling GP, Keelan S, Cosgrove NS, Daly GR, Giblin K, Toomey S, et al. Receptor Discordance in Metastatic Breast Cancer; a review of clinical and genetic subtype alterations from primary to metastatic disease. Breast Cancer Research and Treatment. 2024;207(3):471-476. doi:10.1007/s10549-024-07431-6
BibTeX
@article{Dowling2024,
author = {Dowling, Gavin P and Keelan, Stephen and Cosgrove, Nicola S and Daly, Gordon R and Giblin, Katie and Toomey, Sinead and Hennessy, Bryan T and Hill, Arnold D K},
title = {Receptor Discordance in Metastatic Breast Cancer; a review of clinical and genetic subtype alterations from primary to metastatic disease},
journal = {Breast Cancer Research and Treatment},
year = {2024},
volume = {207},
number = {3},
pages = {471--476},
doi = {10.1007/s10549-024-07431-6}
}
EUVIMED